Close Menu

A triumphant Eric Green took the podium this morning to officially kick off the ninth annual Advances in Genome Biology and Technology meeting here in Marco Island, Fla. Thanks to a burst of interest in sequencing technologies and the scientific applications they're enabling, this year's conference is some 30 percent bigger than its previous record, he told attendees. "There's a tremendous amount of large-scale sequencing" to be done, Eric said -- despite the feeling in previous years that sequencing was past its prime.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.